Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Arhaus

China Automotive Systems

Costco

Manchester United

Philip Morris

Walmart

Despite recent promising signs, macro concerns like inflation, interest rates and a possible recession will likely continue to weigh on the stock market in the near-term. A sustained recovery for stocks, including consumer stocks to buy and hold, may still take some time to take shape.

7 Consumer Stocks to Buy and Hold for Years

Best Buy

Bank of Montreal

Blackstone Group

Canadian Imperial Bank of Commerce

Devon Energy

Realty Income Corp

Millionaire investors searching for income stocks to buy have a different problem than the rest of the market players. They need to balance their portfolio's preservation of capital against generating income on capital.

7 Income Stocks for the Millionaire Portfolio

Autodesk

ASML Hld

Intel

Live Nation

Pool

RCI Hospitality

Scienjoy Holding Corp

Taiwan Semiconductor Manufacturing

If you look hard enough, you can find companies with unusual competitive advantages.

Companies With Economic Moats You Might Have Missed

Altria Group's adjusted diluted EPS payout ratio is poised to come in at 75.2% in 2022, which is a bit better than its 75.5% payout ratio in 2021. Factoring out its wine business, the tobacco company's revenue net of excise taxes edged 0.4% higher while its adjusted diluted EPS increased 4% through the first three quarters of 2022.

Altria Group: Stuff Your Stocking With This High-Yielding Dividend Stock

Medifast

These two stocks offer whopping dividend yields ranging from 5.5% to 8%.

Got $1,000? 2 Ultra High-Yield Dividend Stocks to Get Your Hands On

One of the few stocks that can pay you more than inflation.

Sleep Well at Night in 2023 With This 8.5% Dividend Stock

There is an eerie similarity between the end of 2021 and end of 2022. Defensive names are once again beginning to hold up better.

Altria's 2023: More Like 2022

AbbVie

Kinder Morgan

The Santa Claus rally is a noted phenomenon whereby the stock market tends to rally during the week leading up to Christmas. Many theories about the reason for the phenomenon have been posited including optimism from the holiday spirit, increased shopping, and businesses settling their books before vacation.

3 Dividend Stocks to Buy in Case the Santa Rally Doesn't Come

Altria (MO) gains from its pricing power and focus on Oral Tobacco Products amid a rising cost scenario.

Altria (MO) Looks Well-Poised on Pricing, Oral Tobacco Products

Reaching $1,000 in dividend income might be more within reach than you expect with this high-yielding Dividend King.

Want $1,000 in Dividends in 2023? Buy 266 Shares of This Consumer Stock.

Dollar General

Keurig Dr Pepper Inc

Mondelez

Once in a while, an incredible headline hits the financial media or press and goes something like this: “People Making $100,000 to $200,000 Are Living Paycheck to Paycheck.

As Wealthy Consumers Trade Down, 6 ‘Strong Buy' Dividend Stocks May Be Big Holiday Winners

Coterra Energy

ONEOK

Simon Property Group

Verizon

There has been a glimmer of hope on the horizon for stock investors recently, and while the all-clear rally flag is not being waved, it does appear that some of the worst is behind us.

5 of the Highest Yielding S&P 500 Stocks Have Explosive Potential if Santa Claus Rally Is on Time

Chevron

Exxon Mobil

High-dividend ETFs are just about the only diversified funds up this year. And most of them agree on the S&P 500 stocks you need to own.

Top Investors Reveal 7 High-Dividend Stocks You Should Own

Agree Realty

AFC Gamma

Coca-Cola

Kohl's

Prologis

High-yielding dividend stocks have been some of the safest investments of 2022. In fact, “The recent outperformance of dividend stocks is contrary to the traditional wisdom that they tend to lag the overall market in a rising-rate environment.

7 Juicy Dividends to Be Thankful For This Year

Altria Group's monstrous dividend yield is nearly 9%.

Searching for Huge Passive Income? Buy This Dividend King

British American Tobacco

For 4 years, we've preferred MO to BTI. But following the ban of IQOS in the US, the failure of JUUL to succeed, and the stagnating oral tobacco segment, I am forced to reconsider our position.

Altria Vs. British American Tobacco: If I Had To Pick One

A. O. Smith

Enbridge

First of Long Island

Fresenius Medical Care

Federal Realty Investment Trust

Gorman-Rupp

Lowe's

National Fuel Gas

Polaris

Stanley Black & Decker

Black Friday is a time to gorge on the world's best blue-chip bargains, not just left-over turkey. Today FMS, PII, MO, SWK, LOW, AOS, GRC, NFG, FLIC, ENB, and FRT represent the best Black Friday dividend deals on Wall Street.

11 Black Friday Dividend Aristocrat Deals

The case for Altria is intriguing for a certain type of investor, but it is not without risk.

1 Green Flag for Altria Stock, and 1 Red Flag

AT&T

Vale S.A.

Vornado Realty Trust

In a logical world, one would think, with the Federal Reserve raising interest rates all year long, that rates across the entire Treasury yield curve would head higher.

With Inflation and Interest Rates Falling, 8 Blue Chips With Huge Dividends Are ‘Strong Buys'

Macy's

There are many misconceptions about dividend stocks. The conventional wisdom is that dividend stocks are safe investments that provide shareholders with a steady and reliable income stream.

3 Dividend Stocks to Sell Right Now

Altria Group, Inc. narrowed its EPS guidance for FY 2022. Capital returns and dividend growth are good reasons to buy Altria.

Why I Am Buying 8.5% Yielding Altria

A recent UBS downgrade is nothing new for Altria Group investors. At $38, Altria Group stock should be a steal on so many levels.

Altria: Ridiculous Downgrade

News for Altria Stock (MO)